» Articles » PMID: 30777721

Neutrophil Degranulation, Plasticity, and Cancer Metastasis

Overview
Journal Trends Immunol
Date 2019 Feb 20
PMID 30777721
Citations 174
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophils are the first responders to inflammation and infection. Recently, an elevated neutrophil-to-lymphocyte ratio has generally become a prognostic indicator of poor overall survival in cancer. Accordingly, heterogeneous ill-defined neutrophil-like populations have been increasingly recognized as important players in cancer development. In addition, neutrophil granule proteins released upon cell activation have been associated with tumor progression; this differential granule mobilization may allow neutrophils - and possibly associated cancer cells - to leave the bloodstream and enter inflamed/infected tissues. This review discusses and proposes how granule mobilization may facilitate neutrophil-mediated transport of cancer cells into different tissues as well as leading to different cellular phenotypes that underlie remarkable neutrophil plasticity. This concept might inform novel neutrophil-centered approaches to putative cancer therapies.

Citing Articles

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P Cancers (Basel). 2025; 17(5).

PMID: 40075679 PMC: 11899103. DOI: 10.3390/cancers17050832.


Comparative analysis of protein expression between oesophageal adenocarcinoma and normal adjacent tissue.

Nicholas B, Bailey A, McCann K, Walker R, Johnson P, Elliott T PLoS One. 2025; 20(3):e0318572.

PMID: 40073002 PMC: 11902292. DOI: 10.1371/journal.pone.0318572.


The success of the tumor immunotherapy: neutrophils from bench to beside.

Zhu M, Jia R, Zhang X, Xu P Front Immunol. 2025; 16:1524038.

PMID: 39925807 PMC: 11802522. DOI: 10.3389/fimmu.2025.1524038.


Association of immunosuppressive CD45CD33CD14 CD10HLA-DR neutrophils with poor prognosis in patients with lymphoma and their expansion and activation through STAT3/arginase-1 pathway .

Xiao M, Zhou J, Zhang W, Ding Y, Guo J, Liang X Cytojournal. 2025; 21:69.

PMID: 39916996 PMC: 11801647. DOI: 10.25259/Cytojournal_165_2024.


GTPase GPN3 facilitates cell proliferation and migration in non-small cell lung cancer by impeding clathrin-mediated endocytosis of EGFR.

Xu L, Guo J, Xie X, Wang H, Jiang A, Huang C Cell Death Discov. 2025; 11(1):38.

PMID: 39893205 PMC: 11787391. DOI: 10.1038/s41420-025-02317-y.